Apremilast

FDA Approved: * July 26, 2023
Pharm Company: * ANNORA
Category: Arthritis

Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. It may also be useful for other immune system-related inflammatory diseases. The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4) and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells.[5] It is taken by mouth.[6] Contents 1 Medical uses 2 Contraindications... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Apremilast 30 mg Oral Tablet, Film Coated
NDC: 31722-085
Labeler:
Camber Pharmaceuticals, Inc.
ApremilastApremilast Kit
NDC: 31722-086
Labeler:
Camber Pharmaceuticals, Inc.
ApremilastApremilast Kit
NDC: 31722-087
Labeler:
Camber Pharmaceuticals, Inc.
Apremilast 30 mg Oral Tablet, Film Coated
NDC: 60219-1410
Labeler:
Amneal Pharmaceuticals Ny LLC
ApremilastApremilast Oral Kit
NDC: 60219-1744
Labeler:
Amneal Pharmaceuticals Ny LLC

Related Brands

Drugs with the same active ingredients